PYX-203

N/A

Report date: 2024/12/06 14:23:22

Base Information

Drug NamePYX-203
Drug Alias Nameanti-CD123PYX-203
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionInterleukin-3 receptor subunit alpha modulators
TargetsInterleukin-3 receptor subunit alpha
Therapy Area/IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, AcuteNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPyxis Oncology IncPfizer Inc
Active IndicationsN/A
Inactive IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, AcuteNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A